<bill session="117" type="s" number="2304" updated="2022-12-31T05:25:48Z">
  <state datetime="2021-06-24">REFERRED</state>
  <status>
    <introduced datetime="2021-06-24"/>
  </status>
  <introduced datetime="2021-06-24"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information.</title>
    <title type="display">DTC Act of 2021</title>
    <title type="short" as="introduced">Drug-Price Transparency for Competition Act of 2021</title>
    <title type="short" as="introduced">DTC Act of 2021</title>
  </titles>
  <sponsor bioguide_id="D000563"/>
  <cosponsors>
    <cosponsor bioguide_id="E000295" joined="2021-07-14"/>
    <cosponsor bioguide_id="G000386" joined="2021-06-24"/>
    <cosponsor bioguide_id="K000383" joined="2021-06-24"/>
  </cosponsors>
  <actions>
    <action datetime="2021-06-24">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-06-24" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
      <reference ref="CR S4780-4781" label="text"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-02-03T00:32:23Z" status="Introduced in Senate">Drug-Price Transparency for Competition Act of 2021 or the DTC Act of 2021 This bill requires consumer advertisements for drugs and biologics covered under Medicare or Medicaid to include the drug's list price. Each violation of this requirement is subject to a civil penalty of not more than $100,000.</summary>
</bill>
